PlainPharmaWatch

CMS Open Payments · Program Year 2024

Vero Biotech Inc.

Vero Biotech Inc. reported $4,408.17 in payments to 9 physicians and teaching hospitals across 9 transactions.

See the rankings → How this is sourced
$4.4K
Total payments
9
Transactions
9
Recipients
−$23.6K
General Payments vs PY2023

Vero Biotech Inc. reported $4,408.17 in payments to 9 physicians and teaching hospitals in CMS Open Payments Program Year 2024 - ranking #1727 of 1,925 reporting manufacturers (0.0% of all US industry payments), averaging $489.80 per recipient across 2 payment categories. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the editorial team.

The verdict

Vero Biotech Inc. pairs modest payment volume with a concentrated payment pattern focused on a handful of top recipients.

#1727
of 1,925 companies
0.0%
of all US industry payments
0.8%
paid to its single top recipient
2
payment categories

Release-over-release change

General Payments changed from PY2023 to PY2024

Vero Biotech Inc.'s CMS-reported General Payments decreased by $23.6K (−84.2%) from PY2023 to PY2024. The comparison uses the same CMS manufacturer-by-payment-category summary for both years and excludes research and ownership or investment records.

CMS source labels for this exact identifier: PY2022: VERO BIOTECH INC.PY2023: VERO BIOTECH INC.PY2024: Vero Biotech Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.

Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.

General Payments: PY2023 vs PY2024

Annual CMS-reported totals for this company, not an all-category Open Payments total

PY2023$28.0KPY2024$4.4K
PY2023
$27,971.07
PY2024
$4,408.17

How Vero Biotech Inc. ranks nationally

Where this company's total reported payments fall within the full national distribution of all 1,925 companies in CMS Open Payments, not just its nearest peers.

Vero Biotech Inc.'s total vs. every reporting company

CMS Open Payments, Program Year 2024

$4,408 10th percentile higher than 10% of 1,925 reporting companies

$9–$28: 3 reporting companies (0%). Below this entry. $28–$87: 10 reporting companies (1%). Below this entry. $87–$270: 20 reporting companies (1%). Below this entry. $270–$838: 41 reporting companies (2%). Below this entry. $838–$2,603: 76 reporting companies (4%). Below this entry. $2,603–$8,084: 114 reporting companies (6%). This entry sits in this band. $8,084–$25,112: 167 reporting companies (9%). Above this entry. $25,112–$78,003: 249 reporting companies (13%). Above this entry. $78,003–$242,294: 295 reporting companies (15%). Above this entry. $242,294–$752,621: 270 reporting companies (14%). Above this entry. $752,621–$2,337,813: 263 reporting companies (14%). Above this entry. $2,337,813–$7,261,783: 200 reporting companies (10%). Above this entry. $7,261,783–$22,556,757: 133 reporting companies (7%). Above this entry. $22,556,757–$70,066,439: 45 reporting companies (2%). Above this entry. $70,066,439–$217,642,369: 26 reporting companies (1%). Above this entry. $217,642,369–$676,046,922: 13 reporting companies (1%). Above this entry. This company $9 $676,046,922 every reporting company, bucketed by value

Each bar is a progressively wider band; taller bars hold more reporting companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Open Payments · 2024

What the Data Shows for Vero Biotech Inc.

In Program Year 2024, Vero Biotech Inc. reported $4,408.17 in payments to 9 physicians and teaching hospitals across 9 individual transactions, an average of $489.80 per transaction and $489.80 per recipient. That total places Vero Biotech Inc. at rank #1727 out of 1,925 companies in the CMS Open Payments database, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.

Of the 2 general-payment categories charted below, "Consulting Fee" is the largest at $3.7K across 1 transactions, 83.7% of the company's reported total (see our methodology for how research and ownership payments are reported separately).

General Payment Breakdown by Type

Vero Biotech Inc. made 2 types of general payments. "Consulting Fee" is the largest category at $3.7K, 83.7% of the company's reported total.

How Vero Biotech Inc. divides its payments

Ranked by total dollars reported per category

1. Consulting Fee$3.7K2. Food and Beverage$718.17
Payment Type Amount Transactions
Consulting Fee $3.7K 1
Food and Beverage $718.17 8

Recipient Concentration in General Payments

The five largest recipient relationships account for $4,220.14 (95.7%) of $4,408.17 in this company's General Payments records across 7 recipients. This is a CMS Open Payments Program Year 2024 General Payments view only: it excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Vero Biotech Inc.

The five named recipients with the highest reported General Payments from this company

Mark David Twite$3.7KJohn Wesley McConnell$218.53Puneeta Sarma Vasa$118.45Tiffany A Taylor$96.58Cynthia Mcclellan$96.58
  1. 1

    Mark David Twite

    $3,690.00 across 1 reported transactions

  2. 2

    John Wesley McConnell

    $218.53 across 2 reported transactions

  3. 3

    Puneeta Sarma Vasa

    $118.45 across 2 reported transactions

  4. 4

    Tiffany A Taylor

    $96.58 across 1 reported transactions

  5. 5

    Cynthia Mcclellan

    $96.58 across 1 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Payment Size Analysis

Average transaction size: $489.80. Average per recipient: $489.80.

Total Amount

$4,408.17

Avg per Transaction

$489.80

Avg per Recipient

$489.80

Payment Transparency Context

What is the Sunshine Act?

The Physician Payments Sunshine Act (part of the Affordable Care Act) requires pharmaceutical and medical device manufacturers to report payments and transfers of value to physicians and teaching hospitals. These payments can include consulting fees, research grants, speaker fees, food and beverages, travel, royalties, and other forms of compensation.

Industry Total (2024)

$13.9B

across 1,925 companies

Vero Biotech Inc. Share

0.0%

#1727 by total payments

Companies with Similar Payment Volumes

Pharmaceutical companies with payment totals similar to Vero Biotech Inc.

Pajunk Medical Systems, LP

$4.4K 95 recipients

Cosa Medical, Llc

$4.3K 46 recipients

VivaQuant Inc, dba Rhythm Express

$4.5K 257 recipients

Ensemble Orthopedics, Inc

$4.3K 46 recipients

Dornier MedTech America, Inc

$4.3K 38 recipients

Ferring Sendirian Berhad

$4.3K 1 recipients

Frequently Asked Questions

How much did Vero Biotech Inc. pay to physicians and hospitals in 2024? ▾
Vero Biotech Inc. made $4,408.17 in payments to physicians and hospitals in Program Year 2024, across 9 individual transactions. This represents 0.0% of all industry payments reported to CMS Open Payments.
How many physicians received payments from Vero Biotech Inc.? ▾
Averaging $489.80 per recipient, Vero Biotech Inc.'s 2024 payments reached 9 physicians and teaching hospitals.
What types of payments did Vero Biotech Inc. make? ▾
Vero Biotech Inc. made 2 different types of general payments (consulting, meals, travel, and similar categories). The largest general-payment category was "Consulting Fee" at $3.7K, representing 83.7% of the company's reported total.
How does Vero Biotech Inc. rank among pharmaceutical companies? ▾
Out of 1,925 companies in the CMS Open Payments database for 2024, Vero Biotech Inc. ranks #1727 by total payment amount.
What is the average payment size from Vero Biotech Inc.? ▾
The average transaction from Vero Biotech Inc. was $489.80 in 2024. The company made 9 total transactions to 9 recipients.
Where does the payment data for Vero Biotech Inc. come from? ▾
This data comes from the CMS Open Payments program (Sunshine Act), which requires pharmaceutical and medical device companies to report payments and transfers of value to physicians and teaching hospitals. The data covers Program Year 2024.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch Editorial
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download Vero Biotech Inc.'s data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-25.